Position in REGN
as of Dec 31, 2025
· filed Jan 14, 2026
Position Value
$53,245
+$31,885 QoQ
Shares Held
69
+81.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025ORG Partners LLC holds $451,319 across 39 Biotechnology names. REGN ranks #4 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
657 | $114,334 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
193 | $87,478 | |
| 3 | LCTX |
Lineage Cell Therapeutics, Inc.
|
34,600 | $57,782 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
69 | $53,245 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
73 | $29,020 | |
| 6 | IMNM |
Immunome Inc.
|
880 | $18,900 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
136 | $10,400 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
33 | $10,024 |
All Filings in REGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $53,245 | 69 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $21,360 | 38 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $21,000 | 40 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $8,243 | 13 | Shares | Sole | 2025-04-21 | |
| No filing history on record for this holder in this stock. | ||||||